These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26759218)

  • 1. Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease.
    Bartnicki P; Kowalczyk M; Franczyk-Skóra B; Baj Z; Rysz J
    Curr Vasc Pharmacol; 2016; 14(4):360-7. PubMed ID: 26759218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between asymmetric dimethylarginine plasma level and left ventricular mass in hemodialysis patients.
    El Shahawy Y; Soliman Y; Rifaie A; Shenawy H; Behairy M; Mady G
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):26-33. PubMed ID: 25579712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.
    Zoccali C; Mallamaci F; Maas R; Benedetto FA; Tripepi G; Malatino LS; Cataliotti A; Bellanuova I; Böger R;
    Kidney Int; 2002 Jul; 62(1):339-45. PubMed ID: 12081596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D levels and other biochemical parameters of mineral bone disorders and their association with diastolic dysfunction and left ventricular mass in young nondiabetic adult patients with chronic kidney disease.
    Sonkar SK; Bhutani M; Sonkar GK; Pandey SK; Chandra S; Bhosale V
    Saudi J Kidney Dis Transpl; 2017; 28(4):758-763. PubMed ID: 28748877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum asymmetric dimethylarginine and left ventricular structure and function in patients with end‑stage renal disease treated with hemodialysis.
    Napora M; Graczykowska A; Próchniewska K; Zdrojewski Z; Całka A; Górny J; Stompór T
    Pol Arch Med Wewn; 2012; 122(5):226-34. PubMed ID: 22538734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Asymmetric Dimethylarginine Serum Level and Left Ventricular Function by 2D Speckle Tracking Echocardiography in Children on Regular Hemodialysis.
    El-Salam MA; Abdelrahman T; Youssef M; Osama F; Youssef N
    Saudi J Kidney Dis Transpl; 2022; 33(2):259-271. PubMed ID: 37417178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between endothelial dysfunction and left ventricular remodeling in patients with chronic kidney disease.
    Peng T; Hu Z; Wu L; Li D; Yang X
    Kidney Blood Press Res; 2014; 39(5):420-6. PubMed ID: 25412643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
    Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine.
    Kajimoto H; Kai H; Aoki H; Yasuoka S; Anegawa T; Aoki Y; Ueda S; Okuda S; Imaizumi T
    Kidney Int; 2012 Apr; 81(8):762-8. PubMed ID: 22297680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methylarginies-induced endothelial dysfunction in chronic kidney disease].
    Kimura K
    Yakugaku Zasshi; 2012; 132(4):443-8. PubMed ID: 22465920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
    Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M
    Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive role of endothelin in left ventricular remodeling of chronic kidney disease.
    Peng T; Li X; Hu Z; Yang X; Ma C
    Ren Fail; 2018 Nov; 40(1):183-186. PubMed ID: 29587563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of rapid atrial pacing on ADMA and endothelial NOS.
    Goette A; Hammwöhner M; Bukowska A; Scalera F; Martens-Lobenhoffer J; Dobrev D; Ravens U; Weinert S; Medunjanin S; Lendeckel U; Bode-Böger SM
    Int J Cardiol; 2012 Jan; 154(2):141-6. PubMed ID: 20926145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease.
    Rudenko TE; Kamyshova ES; Vasilyeva MP; Bobkova IN; Solomakhina NI; Shvetsov MY
    Ter Arkh; 2018 Sep; 90(9):60-67. PubMed ID: 30701737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis.
    Inci U; Yildiz A; Batmaz I; Tekbas E
    Int J Rheum Dis; 2017 Feb; 20(2):238-244. PubMed ID: 26012572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na
    Bai XJ; Hao JT; Wang J; Zhang WF; Yan CP; Zhao JH; Zhao ZQ
    Pharmacol Rep; 2018 Feb; 70(1):60-68. PubMed ID: 29331788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.
    Shi B; Ni Z; Zhou W; Yu Z; Gu L; Mou S; Fang W; Wang Q; Cao L; Yan Y; Qian J
    Eur J Intern Med; 2010 Oct; 21(5):444-8. PubMed ID: 20816602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
    Takiuchi S; Fujii H; Kamide K; Horio T; Nakatani S; Hiuge A; Rakugi H; Ogihara T; Kawano Y
    Am J Hypertens; 2004 Sep; 17(9):802-8. PubMed ID: 15363823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
    Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.